Skip to main content
. 2023 Feb 23;10:1056064. doi: 10.3389/fmed.2023.1056064

Table 2.

Incidences of adverse pregnancy outcomes and neonatal outcomes for the single age group.

Variables Total A1 (%) A2 (%) A3 (%) AMA (%) vAMA (%) p
n 15,861 2,586 8,057 3,636 1,314 268
Gestational hypertension 740 (4.67) 68 (2.63) 317 (3.93) 177 (4.87) 136 (10.35) 42 (15.67) 0.00***
Eclampsia/pre-eclampsia 537 (3.39) 31 (1.20) 230 (2.85) 146 (4.02) 97 (7.38) 33 (12.31) 0.00***
Gestational diabetes mellitus 3,633 (22.91) 481 (18.60) 1,736 (21.55) 883 (24.28) 436 (33.18) 97 (36.19) 0.00***
Intrahepatic cholestasis of pregnancy 374 (2.36) 59 (2.28) 201 (2.49) 77 (2.12) 29 (2.21) 8 (2.99) 0.70
Anemia 262 (1.65) 36 (1.39) 118 (1.46) 74 (2.04) 27 (2.05) 7 (2.61) 0.06
Placenta previa 279 (1.76) 20 (0.77) 81 (1.01) 80 (2.20) 77 (5.86) 21 (7.84) 0.00***
Placental abruption 174 (1.10) 27 (1.04) 83 (1.03) 43 (1.18) 17 (1.29) 4 (1.49) 0.83
Placental implantation 170 (1.07) 28 (1.08) 71 (0.88) 33 (0.91) 29 (2.21) 9 (3.36) 0.00***
Premature rupture of membrane 2,843 (17.92) 478 (18.48) 1,492 (18.52) 618 (17.00) 211 (16.06) 44 (16.42) 0.09
Postpartum hemorrhage 665 (4.19) 82 (3.17) 304 (3.77) 164 (4.51) 89 (6.77) 26 (9.70) 0.00***
Oligohydramnios 741 (4.67) 116 (4.49) 371 (4.60) 168 (4.62) 64 (4.87) 22 (8.21) 0.09
Preterm birth 1,870 (11.79) 293 (11.33) 907 (11.26) 413 (11.36) 211 (16.06) 46 (17.16) 0.00***
Cesarean section 8,878 (55.97) 1,123 (43.43) 4,133 (51.30) 2,338 (64.30) 1,063 (80.90) 221 (82.46) 0.00***
Macrosomia 549 (3.46) 90 (3.48) 258 (3.20) 137 (3.77) 55 (4.19) 9 (3.36) 0.32
Fetal distress 120 (0.76) 33 (1.28) 65 (0.81) 15 (0.41) 6 (0.46) 1 (0.37) 0.002**
Transfer to neonatal unit 2,296 (14.48) 309 (11.95) 1,120 (13.90) 540 (14.85) 256 (19.48) 71 (26.49) 0.00***
Neonatal jaundice 778 (4.91) 119 (4.60) 394 (4.89) 171 (4.70) 73 (5.56) 21 (7.84) 0.14
Apgar score <7 within 5 min of birth 278 (1.75) 33 (1.28) 127 (1.58) 72 (1.98) 36 (2.74) 10 (3.73) 0.00***

*p < 0.05, statistically difference, **p < 0.01, statistically significant difference, and ***p < 0.001, highly statistically significant difference. A1: 20–24 years old women, A2: 25–29 years old women, A3: 30–34 years old women, AMA: 35–39 years old women, and vAMA: ≥40 years old women.